http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories
-
Optimizerx Corporation (OPRX) Announces CEO Change
-
OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO
-
OptimizeRx Reports Third Quarter 2024 Financial Results
-
OptimizeRx Reports Second Quarter 2024 Financial Results
-
Optimizerx Corporation (OPRX) Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
-
OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation
-
OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients
-
OptimizeRx Reports First Quarter 2024 Financial Results
-
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
-
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
-
Optimizerx (OPRX) Announces Strategic Board Changes
-
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
-
Optimizerx Corporation (OPRX) Reports Select Prelim FY23 Results, Provides a Business Update
-
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
-
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
-
OptimizeRx Reports Third Quarter 2023 Financial Results
-
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
-
Optimizerx Corporation (OPRX) to Acquire Medicx Health for $95M
-
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
-
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
-
Optimizerx Corporation (OPRX) Expands AI Powered Omnichannel Platform
-
OptimizeRx Expands AI Powered Omnichannel Platform
-
OptimizeRx Reports Second Quarter 2023 Financial Results
-
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
-
Optimizerx's (OPRX) CEO Provides 2023 Midyear Strategic Update
-
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
-
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
-
OptimizeRx to Participate in Upcoming Investor Conferences
-
OptimizeRx Reports First Quarter 2023 Financial Results
-
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
-
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
-
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
-
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
-
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
-
OptimizeRx Releases 2023 Environmental, Social and Governance (ESG) Report
-
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
-
Financial Times Ranks OptimizeRx Amongst The Americas’ Fastest Growing Companies for the Fourth Consecutive Year
-
Optimizerx Corporation (OPRX) Authorizes $15 Million Share Repurchase Program
-
OptimizeRx Authorizes $15 Million Share Repurchase Program
-
OptimizeRx Authorizes $15 Million Share Repurchase Program
-
Optimizerx Corporation (OPRX) Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
-
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
-
OptimizeRx Announces Multi-Year Agreement with Top Hub Services Provider to Accelerate Access for Patients
-
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
-
OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
-
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET
-
OptimizeRx Sets Fourth Quarter & Fiscal Year 2022 Conference Call for March 8, 2023 at 4:30 p.m. ET

